Condor Capital Management’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,030
| Closed | -$20K | – | 417 |
|
|
2022
Q3 | $20K | Hold |
2,030
| – | – | ﹤0.01% | 377 |
|
|
2022
Q2 | $20K | Sell |
2,030
-350
| -15% | -$3.45K | ﹤0.01% | 363 |
|
|
2022
Q1 | $23K | Hold |
2,380
| – | – | ﹤0.01% | 321 |
|
|
2021
Q4 | $24K | Hold |
2,380
| – | – | ﹤0.01% | 288 |
|
|
2021
Q3 | $24K | Hold |
2,380
| – | – | ﹤0.01% | 255 |
|
|
2021
Q2 | $24K | Hold |
2,380
| – | – | ﹤0.01% | 250 |
|
|
2021
Q1 | $23K | Buy |
+2,380
| New | +$23K | ﹤0.01% | 244 |
|